Chemotherapy of parasitic diseases. Current status and new directions.
Liu
Y
Y
Institute of Infectious and Parasitic Diseases, Chongqing University of Medical Sciences.
D000666:Amphotericin B / Q000627:therapeutic use*; D000962:Antimalarials / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D037621:Artemisinins; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000188:drug therapy; D016778:Malaria, Falciparum / Q000188:drug therapy; D010272:Parasitic Diseases / Q000188:drug therapy*; D011223:Praziquantel / Q000627:therapeutic use; D012554:Schistosomiasis japonica / Q000188:drug therapy; D012556:Schistosomicides / Q000627:therapeutic use; D012717:Sesquiterpenes / Q000627:therapeutic use*
D000962:Antimalarials; D000981:Antiprotozoal Agents; D037621:Artemisinins; D012556:Schistosomicides; D012717:Sesquiterpenes; D011223:Praziquantel; D000666:Amphotericin B; C031327:artemisinin